奥精医疗：BioVeda China RMB Investment Limited持股比例已降至5%

Group 1 - The core point of the article is that BioVeda China RMB Investment Limited has reduced its stake in Aojing Medical by selling 388,900 shares, bringing its total holdings to 6.8504 million shares, which now represents 5% of the company's total equity, down from 5.28% [1] - The reduction in shareholding was a voluntary decision made by the shareholder based on its own funding needs, and there is a possibility of further reductions within the next 12 months [1] - The shares held by the shareholder are not subject to any pledges or restrictions such as freezing [1]